EACA
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Abdominal pain | x | x | x | ||
| Agranulocytosis | x | x | x | ||
| Anaphylactic shock | x | x | x | ||
| Coagulopathy | x | x | x | ||
| Confusional state | x | x | x | ||
| Delirium | x | x | x | ||
| Diarrhoea | x | x | x | ||
| Dizziness | x | x | x | ||
| Dyspnoea | x | x | x | ||
| Oedema | x | x | x | ||
| Rash | x | x | x | ||
| Hallucination | x | x | x | ||
| Headache | x | x | x | ||
| Hypersensitivity | x | x | x | ||
| Hypotension | x | x | x | ||
| Leukopenia | x | x | x | ||
| Myopathy | x | x | x | ||
| Myositis | x | x | x | ||
| Nasal congestion | x | x | x | ||
| Nausea | x | x | x | ||
| Necrosis | x | x | |||
| Pain | x | x | |||
| Pruritus | x | x | x | ||
| Pulmonary embolism | x | x | x | ||
| Renal failure | x | x | x | ||
| Rhabdomyolysis | x | x | x | ||
| Convulsion | x | x | x | ||
| Cerebrovascular accident | x | x | x | ||
| Syncope | x | x | x | ||
| Thrombocytopenia | x | ||||
| Thrombosis | x | x | x | ||
| Tinnitus | x | x | x | ||
| Vomiting | x | x | x | ||
| Blood urea increased | x | x | x | ||
| Creatine phosphokinase increased | x | x | x | ||
| Injection site reaction | x | x | |||
| Intracranial pressure increased | x | x | x | ||
| Muscular weakness | x | x | x | ||
| Malaise | x | x | x | ||
| Myalgia | x | x | x | ||
| Peripheral ischaemia | x | x | x | ||
| Anaphylactoid reaction | x | x | x | ||
| Bradycardia | x | x | x | ||
| Local reaction | x | x | |||
| Tearing eyes | x | x | x | ||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
